ALLOX is a startup based in Spain. Brouky records 1 investor associated with the company.
ALLOX develops an AI-enabled platform for the systematic discovery of allosteric drug targets to accelerate the development of innovative therapies for previously undruggable proteins, including preclinical development of selective allosteric inhibitors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.